XY153 (compound 8l) is a BD2-selective BET inhibitor that binds BRD4 BD2 with an IC50 of 0.79 nM, BRD3 BD2 with an IC50 of 5.31 nM, and BRD2 BD2 with an IC50 of 5.09 nM. XY153 is used to study acute myeloid leukaemia and cancer.
Molecular Weight:
555.64
Formula:
C33H34FN3O4
Target:
Others|||Epigenetic Reader Domain
* VAT and and shipping costs not included. Errors and price changes excepted